Early research (Phase 1)Active Not RecruitingNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Testing effectiveness (Phase 2)WithdrawnNCT03005015What this trial is testingLenvatinib in Second Line Endometrial CarcinomaWho this might be right forEndometrial Neoplasms European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07170982What this trial is testingFruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial CancerWho this might be right forEndometrial Cancer Sun Yat-sen University 128
Early research (Phase 1)Active Not RecruitingNCT02715284What this trial is testingStudy of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid TumorsWho this might be right forNeoplasms Tesaro, Inc. 729
Early research (Phase 1)Active Not RecruitingNCT05691504What this trial is testingTesting the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial CancersWho this might be right forAdvanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more National Cancer Institute (NCI) 42
Early research (Phase 1)Looking for participantsNCT07106827What this trial is testingGV20-0251 in Advanced or Refractory Solid TumorsWho this might be right forHCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more West China Hospital 10
Early research (Phase 1)Study completedNCT04293094What this trial is testingStudy of AMG 650 in Adult Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Volastra Therapeutics, Inc. 66
Not applicableLooking for participantsNCT03621904What this trial is testingPROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial CancerWho this might be right forEndometrial Cancer Stage IIIEndometrial Cancer Stage IVEndometrial Cancer Recurrent Radboud University Medical Center 150
Early research (Phase 1)Study completedNCT01300533What this trial is testingBIND-014 Given to Patients With Advanced or Metastatic CancerWho this might be right forMetastatic CancerCancerSolid Tumors BIND Therapeutics 58
Testing effectiveness (Phase 2)Looking for participantsNCT05669430What this trial is testingGV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor MalignanciesWho this might be right forSolid Tumor, AdultRefractory CancerEndometrial Carcinoma (EC)+4 more GV20 Therapeutics 365
Testing effectiveness (Phase 2)UnknownNCT05955105What this trial is testingILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesWho this might be right forHead and Neck CancerCervical CancerEndometrial Cancer+7 more Innolake Biopharm 200
Testing effectiveness (Phase 2)Looking for participantsNCT06277154What this trial is testingMASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue SarcomaWho this might be right forLeiomyosarcomaLiposarcomaSynovial Sarcoma+8 more HRYZ Biotech Co. 148
Testing effectiveness (Phase 2)UnknownNCT04885413What this trial is testingAn Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anti-PD1（Programmed Cell Death Protein 1） Antibody in Recurrent/ Advanced Stage Endometrial Cancer PatientsWho this might be right forRecurrent/ Advanced Stage Endometrial Cancer Patients Sun Yat-sen University 37
Large-scale testing (Phase 3)UnknownNCT00942357What this trial is testingCarboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial CancerWho this might be right forEndometrial Clear Cell AdenocarcinomaEndometrial Serous AdenocarcinomaStage IA Uterine Corpus Cancer AJCC v7+6 more Gynecologic Oncology Group 813
Early research (Phase 1)Looking for participantsNCT05039801What this trial is testingIACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsWho this might be right forAdvanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more M.D. Anderson Cancer Center 54
Early research (Phase 1)Ended earlyNCT04458259What this trial is testingStudy of PF-07265807 in Participants With Metastatic Solid Tumors.Who this might be right forNeoplasm Metastasis Pfizer 88
Early research (Phase 1)WithdrawnNCT05655598What this trial is testingTAS-116 Plus Palbociclib in Breast and Rb-null CancerWho this might be right forAdvanced Breast CancerTreatment-Refractory Solid TumorsRetinoblastoma Deficiency+4 more Brown University
Early research (Phase 1)Ended earlyNCT06299163What this trial is testingNM32-2668 in Adult Patients With Selected Advanced Solid TumorsWho this might be right forOvarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more Numab Therapeutics AG 11
Early research (Phase 1)Looking for participantsNCT06293898What this trial is testingOpen Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsWho this might be right forEndometrial CancerCervical CancerOvarian Cancer+7 more SystImmune Inc. 280
Early research (Phase 1)Looking for participantsNCT07623369What this trial is testingA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forSolid TumorNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Huahui Health 299